Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.440
-0.040 (-1.15%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $128.81 million as of April 23, 2025. Its market cap has decreased by -58.01% in one year.
Market Cap
128.81M
Enterprise Value
61.44M
1-Year Change
-58.01%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $128.81M, a decrease of -73.61%. That is a compound annual growth rate of -29.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 131.07M | -52.32% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |